According to Apellis Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -NZ$0.54 B. In 2023 the company made an earning of -NZ$0.86 B an increase over its 2022 earnings that were of -NZ$1.06 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.